Add BrightSurf on Google Email

Johns Hopkins Medicine


Hopkins team discovers how DNA changes

Researchers identified a step-by-step process involving TET1 and Apobec1 that converts methylated cytosine into hydroxymethylated cytosine, indicating a potential unified mechanism for DNA methylation status change. The discovery has implications for understanding diseases associated with epigenetic abnormality.

SourceJohns Hopkins Medicine·JournalCell·DateApr 14, 2011

Could HIV-infected organs save lives?

Researchers estimate that lifting the ban on HIV-infected organ donation could provide transplants to 500 patients annually. The study suggests that this change would not only benefit HIV-positive patients but also reduce waiting times for non-HIV infected patients.

SourceJohns Hopkins Medicine·JournalAmerican Journal of Transplantation·DateMar 30, 2011

Computerized systems reduce psychiatric drug errors

Researchers at Johns Hopkins Medicine found that coupling electronic prescription drug ordering systems with computerized adverse event reporting dramatically reduced medication errors in a psychiatric unit from 27.89 to 3.43 per 1,000 patient days over four years. The system's integration of decision support and safety net tools furth...

SourceJohns Hopkins Medicine·JournalJournal of Psychiatric Practice·DateMar 21, 2011

Hopkins researchers use light to move molecules

Researchers at Johns Hopkins Medicine have developed a tool that uses light to move and interact with individual molecules in living cells. This allows for greater control over cellular processes, enabling scientists to study the role of specific proteins and their interactions in cell behavior.

SourceJohns Hopkins Medicine·JournalJournal of the American Chemical Society·DateMar 16, 2011

Insulin-releasing switch discovered

Scientists have identified a protein called Snapin as the molecular switch that controls insulin secretion in pancreatic beta cells. This discovery provides an explanation for the failure of these cells in type 2 diabetes and may lead to new therapies.

SourceJohns Hopkins Medicine·JournalCell Metabolism·DateMar 15, 2011

Solving a traditional Chinese medicine mystery

Researchers at Johns Hopkins Medicine have discovered a natural product from traditional Chinese medicine that blocks gene control machinery in cells, suggesting potential as an anticancer drug. The compound, triptolide, has been shown to be effective against cancer and other conditions.

SourceJohns Hopkins Medicine·JournalNature Chemical Biology·DateMar 3, 2011

Hearing loss and dementia linked in study

Seniors with hearing loss are more likely to develop dementia over time than those with normal hearing. The study found a significant link between the two conditions, with the risk of developing dementia increasing by twofold, threefold, and fivefold for individuals with mild, moderate, and severe hearing loss.

SourceJohns Hopkins Medicine·JournalArchives of Neurology·DateFeb 15, 2011

Military/civilian medical experts turning attention to 'army' of injured civilians supporting wars

A study by Johns Hopkins Medicine found that civilians with noncombat injuries are more likely to be evacuated for treatment, but also more likely to return to work in war zones due to higher salaries. In contrast, soldiers are less motivated to return after such injuries, possibly due to the loss of hazardous duty pay.

SourceJohns Hopkins Medicine·JournalCanadian Medical Association Journal·DateFeb 14, 2011

Johns Hopkins researchers capture jumping genes

Scientists at Johns Hopkins University have discovered a significant number of new insertions of retrotransposon insertion polymorphisms (RIPs) in the human genome, expanding our understanding of genetic diversity. The study highlights the importance of retrotransposons in shaping human traits and disease risks.

SourceJohns Hopkins Medicine·JournalGenome Research·DateFeb 4, 2011